Why Vanda Pharmaceuticals Stock Crawled Higher Today
Earnings season seems to be the pill needed to improve sentiment on Vanda Pharmaceuticals (NASDAQ: VNDA). The commercial-stage biotech saw its share price rise by almost 1% on Thursday, following the release of quarterly results that comfortably topped analyst estimates. The sleep medication's sales were higher in the same period one year ago when it brought in $44 million.